Fei Pan
Fortuna: 57 M $ al 31/07/2026
Fortuna: 57 M $ al 31/07/2026
Fei Pan is currently Chief Executive Officer & Executive Director at Jenscare Scientific Co., Ltd., a position starting in 2026.
Formerly, Mr. Pan was a Portfolio Manager at China International Capital Corp.
Ltd. (Invt Management).
Education includes a graduate degree from the University of Cambridge in 2010, a graduate degree from the University of Warwick in 2009, and an undergraduate degree from the University of Lancaster in 2008.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 13/05/2025 | 63.544.279 ( 20,48 % ) | 57 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| JENSCARE SCIENTIFIC CO., LTD. | Director Ejecutivo | 15/01/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
China International Capital Corp. Ltd. (Invt Management)
China International Capital Corp. Ltd. (Invt Management) Investment ManagersFinance CICC-IM aims to deliver excellent, long-term performance through their proven investment process, established risk management framework and strong research capability. | Gestor de Cartera-Acciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lancaster
University of Lancaster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China International Capital Corp. Ltd. (Invt Management)
China International Capital Corp. Ltd. (Invt Management) Investment ManagersFinance CICC-IM aims to deliver excellent, long-term performance through their proven investment process, established risk management framework and strong research capability. | Finance |
Jenscare Scientific Co. Ltd.
Jenscare Scientific Co. Ltd. Medical SpecialtiesHealth Technology Develops and sells transcatheter aortic valve systems | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.